Gestagens when administered alone to menopausal women, (19 nortestoste
rone or progesterone derivatives) suppress loss of mineral content. Bu
t often a slight bone loss is observed, in contrast to the effect of o
estrogenotherapy. 19 norpregnane derivatives seems to protect against
bone loss. Progestagen may enhance bone formation without decreasing b
one resorption. Administered together with oestrogens, gestagens have
demonstrated either a decrease in biochemical estimates of bone loss o
r a radiologically positive effect. Progestogens alone in premenopausa
l women have various effects. In the case of contraception by injectab
le MPA the bone mass tend to decline as a result of hypoestrogenism. I
n summary gestagens seem to have on bone mass a rather favourable effe
ct, which nevertheless is weaker than that of oestrogen.